{"id":122668,"date":"2025-06-10T00:09:56","date_gmt":"2025-06-09T17:09:56","guid":{"rendered":"https:\/\/vnras.com\/drug\/?post_type=product&p=122668"},"modified":"2025-07-24T13:13:04","modified_gmt":"2025-07-24T06:13:04","slug":"trelegy-ellipta","status":"publish","type":"product","link":"https:\/\/vnras.com\/drug\/trelegy-ellipta\/","title":{"rendered":"Trelegy Ellipta"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n thu\u1ed1c Trelegy Ellipta \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 500110439823<\/strong><\/p>\n

Trelegy Ellipta l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n
Th\u00e0nh ph\u1ea7n<\/h3>\n
Trong m\u1ed7i li\u1ec1u h\u00edt Trelegy Ellipta<\/strong> c\u00f3 ch\u1ee9a:<\/p>\n
\n
Fluticasone furoate 100mcg<\/li>\n
Umeclidinium 62,5mcg (t\u01b0\u01a1ng \u0111\u01b0\u01a1ng v\u1edbi 74,2mcg umeclidinium bromide)<\/li>\n
Vilanterol (d\u1ea1ng trifenatate) 25mcg<\/li>\n<\/ul>\n
D\u1ea1ng b\u00e0o ch\u1ebf: Thu\u1ed1c b\u1ed9t h\u00edt ph\u00e2n li\u1ec1u<\/p>\n
Tr\u00ecnh b\u00e0y<\/h3>\n
S\u0110K: 500110439823<\/p>\n
Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p c\u00f3 1 d\u1ee5ng c\u1ee5 h\u00edt ch\u1ee9a 30 li\u1ec1u h\u00edt<\/p>\n
Xu\u1ea5t x\u1ee9: V\u01b0\u01a1ng qu\u1ed1c Anh<\/p>\n
H\u1ea1n s\u1eed d\u1ee5ng: 24 th\u00e1ng<\/p>\n
T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Trelegy Ellipta<\/h2>\n
C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n
\n
Trelegy Ellipta l\u00e0 s\u1ef1 k\u1ebft h\u1ee3p c\u1ee7a ba ho\u1ea1t ch\u1ea5t thu\u1ed9c c\u00e1c nh\u00f3m d\u01b0\u1ee3c l\u00fd kh\u00e1c nhau: corticosteroid t\u1ed5ng h\u1ee3p, ch\u1ea5t kh\u00e1ng muscarinic t\u00e1c d\u1ee5ng k\u00e9o d\u00e0i (LAMA), v\u00e0 thu\u1ed1c ch\u1ee7 v\u1eadn beta-2 ch\u1ecdn l\u1ecdc t\u00e1c d\u1ee5ng k\u00e9o d\u00e0i (LABA).<\/li>\n
Fluticasone furoate l\u00e0 corticosteroid m\u1ea1nh, c\u00f3 t\u00e1c d\u1ee5ng ch\u1ed1ng vi\u00eam b\u1eb1ng c\u00e1ch \u1ee9c ch\u1ebf ho\u1ea1t \u0111\u1ed9ng c\u1ee7a c\u00e1c t\u1ebf b\u00e0o v\u00e0 ph\u00e2n t\u1eed trung gian trong ph\u1ea3n \u1ee9ng vi\u00eam \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p.<\/li>\n
Umeclidinium ho\u1ea1t \u0111\u1ed9ng b\u1eb1ng c\u00e1ch ng\u0103n ch\u1eb7n th\u1ee5 th\u1ec3 muscarinic tr\u00ean c\u01a1 tr\u01a1n ph\u1ebf qu\u1ea3n, l\u00e0m gi\u1ea3m co th\u1eaft ph\u1ebf qu\u1ea3n v\u00e0 gi\u00fap gi\u00e3n ph\u1ebf qu\u1ea3n hi\u1ec7u qu\u1ea3 trong th\u1eddi gian d\u00e0i.<\/li>\n
Vilanterol k\u00edch th\u00edch th\u1ee5 th\u1ec3 beta-2 adrenergic, l\u00e0m t\u0103ng s\u1ea3n xu\u1ea5t AMP v\u00f2ng, t\u1eeb \u0111\u00f3 th\u01b0 gi\u00e3n c\u01a1 tr\u01a1n \u0111\u01b0\u1eddng d\u1eabn kh\u00ed v\u00e0 gi\u1ea3m gi\u1ea3i ph\u00f3ng c\u00e1c ch\u1ea5t g\u00e2y ph\u1ea3n \u1ee9ng vi\u00eam t\u1ee9c th\u00ec.<\/li>\n<\/ul>\n
\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n
Fluticasone furoate: Sau khi h\u00edt, thu\u1ed1c \u0111\u1ea1t n\u1ed3ng \u0111\u1ed9 \u0111\u1ec9nh trong huy\u1ebft t\u01b0\u01a1ng kho\u1ea3ng 15 ph\u00fat. Sinh kh\u1ea3 d\u1ee5ng to\u00e0n th\u00e2n trung b\u00ecnh kho\u1ea3ng 15%, ch\u1ee7 y\u1ebfu \u0111\u01b0\u1ee3c h\u1ea5p thu t\u1ea1i ph\u1ed5i, r\u1ea5t \u00edt h\u1ea5p thu qua \u0111\u01b0\u1eddng ti\u00eau h\u00f3a. Sau nhi\u1ec1u ng\u00e0y s\u1eed d\u1ee5ng, tr\u1ea1ng th\u00e1i \u1ed5n \u0111\u1ecbnh \u0111\u1ea1t \u0111\u01b0\u1ee3c trong v\u00f2ng 6 ng\u00e0y v\u1edbi s\u1ef1 t\u00edch t\u1ee5 nh\u1eb9. Thu\u1ed1c li\u00ean k\u1ebft m\u1ea1nh v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng (>99,6%) v\u00e0 \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a ch\u1ee7 y\u1ebfu qua enzym CYP3A4, th\u1ea3i tr\u1eeb ch\u1ee7 y\u1ebfu qua ph\u00e2n.<\/p>\n
Umeclidinium: Thu\u1ed1c nhanh ch\u00f3ng \u0111\u1ea1t n\u1ed3ng \u0111\u1ed9 \u0111\u1ec9nh trong kho\u1ea3ng 5 ph\u00fat sau khi h\u00edt. Sinh kh\u1ea3 d\u1ee5ng to\u00e0n th\u00e2n trung b\u00ecnh kho\u1ea3ng 13%, h\u1ea5p thu qua \u0111\u01b0\u1eddng ti\u00eau h\u00f3a r\u1ea5t th\u1ea5p. Thu\u1ed1c g\u1eafn k\u1ebft kho\u1ea3ng 89% v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng, \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a ch\u00ednh b\u1edfi CYP2D6 v\u00e0 th\u1ea3i tr\u1eeb qua ph\u00e2n v\u00e0 n\u01b0\u1edbc ti\u1ec3u. Th\u1eddi gian b\u00e1n th\u1ea3i huy\u1ebft t\u01b0\u01a1ng kho\u1ea3ng 19 gi\u1edd.<\/p>\n
Vilanterol: N\u1ed3ng \u0111\u1ed9 \u0111\u1ec9nh \u0111\u1ea1t trong huy\u1ebft t\u01b0\u01a1ng sau kho\u1ea3ng 7 ph\u00fat h\u00edt thu\u1ed1c, sinh kh\u1ea3 d\u1ee5ng trung b\u00ecnh 27%. Thu\u1ed1c li\u00ean k\u1ebft kho\u1ea3ng 94% v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng v\u00e0 \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a ch\u1ee7 y\u1ebfu qua CYP3A4. Th\u1eddi gian b\u00e1n th\u1ea3i c\u1ee7a Vilanterol l\u00e0 kho\u1ea3ng 11 gi\u1edd, ch\u1ee7 y\u1ebfu th\u1ea3i tr\u1eeb qua n\u01b0\u1edbc ti\u1ec3u v\u00e0 ph\u00e2n d\u01b0\u1edbi d\u1ea1ng c\u00e1c ch\u1ea5t chuy\u1ec3n h\u00f3a.<\/p>\n
Thu\u1ed1c Trelegy Ellipta \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n
Thu\u1ed1c h\u00edt \u0111\u1ecbnh li\u1ec1u Trelegy Ellipta<\/strong> \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb duy tr\u00ec b\u1ec7nh ph\u1ed5i t\u1eafc ngh\u1ebdn m\u1ea1n t\u00ednh (COPD), nh\u1eb1m ph\u00f2ng ng\u1eeba v\u00e0 gi\u1ea3m nh\u1eb9 tri\u1ec7u ch\u1ee9ng.<\/p>\n
$\"Trelegy$
Thu\u1ed1c Trelegy Ellipta l\u00e0 s\u1ef1 thu\u1ed1c ph\u1ed1i h\u1ee3p ba ho\u1ea1t ch\u1ea5t gi\u00fap h\u1ed7 tr\u1ee3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u1ed5i t\u1eafc ngh\u1ebdn m\u1ea1n t\u00ednh (COPD) v\u1edbi c\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng \u0111a di\u1ec7n v\u00e0 hi\u1ec7u qu\u1ea3 k\u00e9o d\u00e0i.<\/figcaption><\/figure>\n
Li\u1ec1u d\u00f9ng v\u00e0 c\u00e1ch s\u1eed d\u1ee5ng<\/h2>\n
Li\u1ec1u d\u00f9ng<\/h3>\n
\n
Ng\u01b0\u1eddi l\u1edbn: 1 li\u1ec1u h\u00edt Trelegy Ellipta 100\/62,5\/25 mcg m\u1ed7i ng\u00e0y.<\/li>\n
Tr\u1ebb em & thanh thi\u1ebfu ni\u00ean: Kh\u00f4ng ph\u00f9 h\u1ee3p v\u1edbi \u0111\u1ed1i t\u01b0\u1ee3ng d\u01b0\u1edbi 18 tu\u1ed5i.<\/li>\n
Ng\u01b0\u1eddi cao tu\u1ed5i & b\u1ec7nh nh\u00e2n suy th\u1eadn: Kh\u00f4ng c\u1ea7n ch\u1ec9nh li\u1ec1u.<\/li>\n
Suy gan: C\u1ea7n th\u1eadn tr\u1ecdng, \u0111\u1eb7c bi\u1ec7t v\u1edbi b\u1ec7nh nh\u00e2n suy gan v\u1eeba ho\u1eb7c n\u1eb7ng.<\/li>\n<\/ul>\n
C\u00e1ch s\u1eed d\u1ee5ng<\/h3>\n
H\u00edt qua mi\u1ec7ng 1 l\u1ea7n\/ng\u00e0y v\u00e0o c\u00f9ng th\u1eddi \u0111i\u1ec3m m\u1ed7i ng\u00e0y (s\u00e1ng ho\u1eb7c t\u1ed1i). Sau khi d\u00f9ng thu\u1ed1c, n\u00ean s\u00fac mi\u1ec7ng b\u1eb1ng n\u01b0\u1edbc (kh\u00f4ng nu\u1ed1t).<\/p>\n
H\u01b0\u1edbng d\u1eabn k\u1ef9 thu\u1eadt h\u00edt chi ti\u1ebft \u0111\u1ecdc trong t\u1edd h\u01b0\u1edbng d\u1eabn s\u1eed d\u1ee5ng c\u00f3 \u0111i k\u00e8m theo trong h\u1ed9p<\/p>\n
$\"H\u01b0\u1edbng$
H\u01b0\u1edbng d\u1eabn k\u1ef9 thu\u1eadt s\u1eed d\u1ee5ng thu\u1ed1c h\u00edt \u0111\u1ecbnh li\u1ec1u Trelegy Ellipta<\/figcaption><\/figure>\n
Kh\u00f4ng s\u1eed d\u1ee5ng thu\u1ed1c Trelegy Ellipta trong tr\u01b0\u1eddng h\u1ee3p n\u00e0o?<\/h2>\n
Ng\u01b0\u1eddi d\u1ecb \u1ee9ng v\u1edbi fluticasone furoate, umeclidinium, vilanterol ho\u1eb7c t\u00e1 d\u01b0\u1ee3c c\u00f3 trong Trelegy Ellipta<\/p>\n
Ng\u01b0\u1eddi c\u00f3 ti\u1ec1n s\u1eed d\u1ecb \u1ee9ng n\u1eb7ng v\u1edbi protein s\u1eefa.<\/p>\n
L\u01b0u \u00fd \u0111\u1eb7c bi\u1ec7t khi s\u1eed d\u1ee5ng thu\u1ed1c<\/h2>\n
Th\u1eadn tr\u1ecdng<\/h3>\n
\n
Kh\u00f4ng d\u00f9ng \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb c\u01a1n c\u1ea5p COPD.<\/li>\n
Kh\u00f4ng t\u1ef1 \u00fd ng\u1eebng thu\u1ed1c m\u00e0 kh\u00f4ng c\u00f3 ch\u1ec9 \u0111\u1ecbnh c\u1ee7a b\u00e1c s\u0129.<\/li>\n
Co th\u1eaft ph\u1ebf qu\u1ea3n ngh\u1ecbch l\u00fd: Hi\u1ebfm g\u1eb7p, nh\u01b0ng c\u1ea7n ng\u1eebng thu\u1ed1c ngay n\u1ebfu x\u1ea3y ra.<\/li>\n
\u1ea2nh h\u01b0\u1edfng tim m\u1ea1ch: C\u1ea7n th\u1eadn tr\u1ecdng v\u1edbi b\u1ec7nh nh\u00e2n c\u00f3 b\u1ec7nh l\u00fd tim m\u1ea1ch kh\u00f4ng \u1ed5n \u0111\u1ecbnh.<\/li>\n
Suy gan: Theo d\u00f5i nguy c\u01a1 t\u00e1c d\u1ee5ng to\u00e0n th\u00e2n c\u1ee7a corticosteroid.<\/li>\n
T\u00e1c d\u1ee5ng to\u00e0n th\u00e2n c\u1ee7a corticosteroid: C\u00f3 th\u1ec3 bao g\u1ed3m suy tuy\u1ebfn th\u01b0\u1ee3ng th\u1eadn, gi\u1ea3m m\u1eadt \u0111\u1ed9 x\u01b0\u01a1ng, t\u0103ng nh\u00e3n \u00e1p,…<\/li>\n
C\u1ea9n tr\u1ecdng tr\u00ean b\u1ec7nh nh\u00e2n b\u1ecb lao ph\u1ed5i, nhi\u1ec5m tr\u00f9ng m\u1ea1n t\u00ednh ch\u01b0a \u0111i\u1ec1u tr\u1ecb.<\/li>\n
B\u1ec7nh t\u0103ng nh\u00e3n \u00e1p g\u00f3c \u0111\u00f3ng & ti\u1ec3u kh\u00f3: D\u00f9ng th\u1eadn tr\u1ecdng do t\u00e1c d\u1ee5ng kh\u00e1ng muscarinic.<\/li>\n
Vi\u00eam ph\u1ed5i: C\u00f3 th\u1ec3 x\u1ea3y ra; c\u1ea7n c\u1ea3nh gi\u00e1c v\u00ec tri\u1ec7u ch\u1ee9ng d\u1ec5 nh\u1ea7m v\u1edbi \u0111\u1ee3t k\u1ecbch ph\u00e1t COPD.<\/li>\n
T\u00e1 d\u01b0\u1ee3c lactose: Kh\u00f4ng d\u00f9ng cho b\u1ec7nh nh\u00e2n kh\u00f4ng dung n\u1ea1p lactose, thi\u1ebfu men lactase b\u1ea9m sinh,<\/li>\n<\/ul>\n
T\u00e1c d\u1ee5ng ph\u1ee5<\/h3>\n
Trong qu\u00e1 tr\u00ecnh s\u1eed d\u1ee5ng Trelegy Ellipta, b\u1ec7nh nh\u00e2n c\u00f3 th\u1ec3 g\u1eb7p c\u00e1c t\u00e1c d\u1ee5ng kh\u00f4ng mong mu\u1ed1n nh\u01b0: vi\u00eam nhi\u1ec5m \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p tr\u00ean, ho k\u00e9o d\u00e0i, c\u1ea3m gi\u00e1c kh\u00f3 ch\u1ecbu ho\u1eb7c \u0111au r\u00e1t \u1edf v\u00f9ng mi\u1ec7ng v\u00e0 h\u1ecdng, nhi\u1ec5m n\u1ea5m Candida t\u1ea1i h\u1ecdng ho\u1eb7c mi\u1ec7ng, \u0111au \u0111\u1ea7u, \u0111au l\u01b0ng ho\u1eb7c c\u00e1c kh\u1edbp x\u01b0\u01a1ng, c\u1ea3m c\u00fam v\u00e0 t\u00e1o b\u00f3n.<\/p>\n
Ngo\u00e0i ra, c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 \u00edt g\u1eb7p bao g\u1ed3m: r\u1ed1i lo\u1ea1n nh\u1ecbp tim (bao g\u1ed3m tim nhanh, rung nh\u0129), thay \u0111\u1ed5i v\u1ecb gi\u00e1c, kh\u00f4 mi\u1ec7ng, kh\u00f3 kh\u0103n trong ph\u00e1t \u00e2m v\u00e0 t\u0103ng nguy c\u01a1 g\u00e3y x\u01b0\u01a1ng.<\/p>\n
T\u01b0\u01a1ng t\u00e1c<\/h3>\n
\n
Thu\u1ed1c ch\u1eb9n beta: Gi\u1ea3m hi\u1ec7u qu\u1ea3 vilanterol \u2013 n\u00ean ch\u1ecdn thu\u1ed1c ch\u1eb9n beta ch\u1ecdn l\u1ecdc v\u00e0 th\u1eadn tr\u1ecdng khi ph\u1ed1i h\u1ee3p.<\/li>\n
Ch\u1ea5t \u1ee9c ch\u1ebf CYP3A4 m\u1ea1nh (ketoconazole, ritonavir): T\u0103ng nguy c\u01a1 t\u00e1c d\u1ee5ng ph\u1ee5 c\u1ee7a fluticasone furoate v\u00e0 vilanterol.<\/li>\n
Ch\u1ea5t \u1ee9c ch\u1ebf CYP2D6: Kh\u00f4ng g\u00e2y \u1ea3nh h\u01b0\u1edfng l\u00e2m s\u00e0ng \u0111\u00e1ng k\u1ec3 \u0111\u1ebfn umeclidinium.<\/li>\n
Ch\u1ea5t \u1ee9c ch\u1ebf P-glycoprotein (nh\u01b0 verapamil): Kh\u00f4ng c\u00f3 t\u01b0\u01a1ng t\u00e1c \u0111\u00e1ng k\u1ec3 tr\u00ean l\u00e2m s\u00e0ng.<\/li>\n
Kh\u00f4ng khuy\u1ebfn c\u00e1o d\u00f9ng k\u00e8m thu\u1ed1c kh\u00e1ng muscarinic k\u00e9o d\u00e0i ho\u1eb7c ch\u1ee7 v\u1eadn beta-adrenergic k\u00e9o d\u00e0i kh\u00e1c.<\/li>\n<\/ul>\n
L\u01b0u \u00fd cho ph\u1ee5 n\u1eef c\u00f3 thai v\u00e0 cho con b\u00fa<\/h3>\n
\n
\u1ea2nh h\u01b0\u1edfng l\u00ean sinh s\u1ea3n: Ch\u01b0a c\u00f3 d\u1eef li\u1ec7u v\u1ec1 t\u00e1c \u0111\u1ed9ng c\u1ee7a Trelegy Ellipta tr\u00ean kh\u1ea3 n\u0103ng sinh s\u1ea3n \u1edf ng\u01b0\u1eddi. Nghi\u00ean c\u1ee9u tr\u00ean \u0111\u1ed9ng v\u1eadt kh\u00f4ng th\u1ea5y \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn sinh s\u1ea3n.<\/li>\n
Thai k\u1ef3: Ch\u01b0a \u0111\u1ee7 d\u1eef li\u1ec7u v\u1ec1 an to\u00e0n khi d\u00f9ng cho ph\u1ee5 n\u1eef mang thai. Thu\u1ed1c ch\u1ec9 d\u00f9ng khi l\u1ee3i \u00edch v\u01b0\u1ee3t tr\u1ed9i nguy c\u01a1 v\u1edbi thai nhi.<\/li>\n
Cho con b\u00fa: Ch\u01b0a r\u00f5 thu\u1ed1c c\u00f3 b\u00e0i ti\u1ebft v\u00e0o s\u1eefa m\u1eb9 kh\u00f4ng, n\u00ean c\u00e2n nh\u1eafc gi\u1eefa l\u1ee3i \u00edch cho m\u1eb9 v\u00e0 nguy c\u01a1 cho tr\u1ebb khi d\u00f9ng thu\u1ed1c ho\u1eb7c cho con b\u00fa.<\/li>\n<\/ul>\n
L\u01b0u \u00fd khi s\u1eed d\u1ee5ng cho ng\u01b0\u1eddi l\u00e1i xe v\u00e0 v\u1eadn h\u00e0nh m\u00e1y m\u00f3c<\/h3>\n
Ch\u01b0a c\u00f3 \u0111\u1ee7 d\u1eef li\u1ec7u v\u00e0 b\u1eb1ng ch\u1ee9ng v\u1ec1 \u1ea3nh h\u01b0\u1edfng c\u1ee7a Trelegy Ellipta tr\u00ean \u0111\u1ed1i t\u01b0\u1ee3ng n\u00e0y<\/p>\n
Qu\u00e1 li\u1ec1u v\u00e0 x\u1eed tr\u00ed<\/h3>\n
Hi\u1ec7n ch\u01b0a ghi nh\u1eadn d\u1eef li\u1ec7u v\u1ec1 qu\u00e1 li\u1ec1u Trelegy Ellipta trong c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng. Qu\u00e1 li\u1ec1u c\u00f3 th\u1ec3 g\u00e2y ra t\u00e1c d\u1ee5ng kh\u00f4ng mong mu\u1ed1n do t\u1eebng th\u00e0nh ph\u1ea7n c\u1ee7a thu\u1ed1c. Kh\u00f4ng c\u00f3 thu\u1ed1c gi\u1ea3i \u0111\u1ed9c \u0111\u1eb7c hi\u1ec7u, \u0111i\u1ec1u tr\u1ecb ch\u1ee7 y\u1ebfu l\u00e0 h\u1ed7 tr\u1ee3 v\u00e0 theo d\u00f5i. C\u00f3 th\u1ec3 c\u00e2n nh\u1eafc d\u00f9ng thu\u1ed1c ch\u1eb9n beta ch\u1ecdn l\u1ecdc tr\u00ean tim n\u1ebfu tri\u1ec7u ch\u1ee9ng do vilanterol nghi\u00eam tr\u1ecdng, nh\u01b0ng c\u1ea7n th\u1eadn tr\u1ecdng \u1edf b\u1ec7nh nh\u00e2n c\u00f3 ti\u1ec1n s\u1eed co th\u1eaft ph\u1ebf qu\u1ea3n. Li\u00ean h\u1ec7 trung t\u00e2m ch\u1ed1ng \u0111\u1ed9c n\u1ebfu c\u1ea7n.<\/p>\n
B\u1ea3o qu\u1ea3n<\/h3>\n
\n
Gi\u1eef Trelegy Ellipta \u1edf n\u01a1i kh\u00f4 r\u00e1o, tho\u00e1ng m\u00e1t (<30\u2103), tr\u00e1nh \u00e1nh n\u1eafng qu\u00e1 m\u1ea1nh t\u1eeb m\u1eb7t tr\u1eddi<\/li>\n
Kh\u00f4ng \u0111\u1ec3 Trelegy Ellipta trong t\u1ea7m v\u1edbi tr\u1ebb em<\/li>\n
Kh\u00f4ng s\u1eed d\u1ee5ng Trelegy Ellipta khi qu\u00e1 h\u1ea1n cho ph\u00e9p<\/li>\n<\/ul>\n
Thu\u1ed1c Trelegy Ellipta gi\u00e1 bao nhi\u00eau? b\u00e1n \u1edf \u0111\u00e2u?<\/h2>\n
Trelegy Ellipta hi\u1ec7n \u0111ang \u0111\u01b0\u1ee3c b\u00e1n t\u1ea1i Nh\u00e0 thu\u1ed1c D\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng, gi\u00e1 thu\u1ed1c Trelegy Ellipta c\u00f3 th\u1ec3 \u0111\u00e3 \u0111\u01b0\u1ee3c c\u1eadp nh\u1eadp t\u1ea1i \u0111\u1ea7u trang. Hi\u1ec7n nay, nh\u00e0 thu\u1ed1c ch\u00fang t\u00f4i h\u1ed7 tr\u1ee3 giao h\u00e0ng to\u00e0n qu\u1ed1c. Qu\u00fd kh\u00e1ch h\u00e0ng c\u00f3 th\u1ec3 li\u00ean h\u1ec7 qua s\u1ed1 hotline \u0111\u1ec3 \u0111\u01b0\u1ee3c t\u01b0 v\u1ea5n k\u1ecbp th\u1eddi.<\/p>\n
Tr\u01b0\u1eddng h\u1ee3p Trelegy Ellipta t\u1ea1m th\u1eddi h\u1ebft h\u00e0ng, qu\u00fd kh\u00e1ch c\u00f3 th\u1ec3 tham kh\u1ea3o c\u00e1c s\u1ea3n ph\u1ea9m kh\u00e1c c\u1ee7a nh\u00e0 thu\u1ed1c c\u00f3 c\u00f9ng ho\u1ea1t ch\u1ea5t v\u00e0 t\u00e1c d\u1ee5ng v\u1edbi Trelegy Ellipta nh\u01b0:<\/p>\n
Zensonid 200 inhaler<\/a> c\u00f3 th\u00e0nh ph\u1ea7n ch\u00ednh l\u00e0 Budesonid 200mcg, \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi C\u00f4ng ty c\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m CPC1 H\u00e0 N\u1ed9i, c\u00f3 t\u00e1c d\u1ee5ng \u0111i\u1ec1u t\u1ecb b\u1ec7nh vi\u00eam ph\u1ed5i t\u1eafc ngh\u1ebdn m\u00e3n t\u00ednh – COPD.<\/p>\n
Breztri Aerosphere<\/a> c\u00f3 th\u00e0nh ph\u1ea7n l\u00e0 Budesonid 160mcg; Glycopyrronium 7,2mcg v\u00e0 Formoterol fumarat dihydrat 5mcg, \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi AstraZeneca Dunkerque Production, c\u00f3 t\u00e1c d\u1ee5ng \u0111i\u1ec1u t\u1ecb b\u1ec7nh vi\u00eam ph\u1ed5i t\u1eafc ngh\u1ebdn m\u00e3n t\u00ednh – COPD.<\/p>\n
T\u00e0i li\u1ec7u tham kh\u1ea3o<\/h2>\n
Verhoeven GT, Hegmans JP, Mulder PG, Bogaard JM, Hoogsteden HC, Prins JB (2002). Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness. Thorax. Truy c\u1eadp ng\u00e0y 10 th\u00e1ng 6 n\u0103m 2025 t\u1eeb: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1746396\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"
Trong b\u00e0i vi\u1ebft n\u00e0y, d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n thu\u1ed1c Trelegy Ellipta \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 500110439823 Trelegy Ellipta l\u00e0 thu\u1ed1c g\u00ec? Th\u00e0nh ph\u1ea7n Trong m\u1ed7i li\u1ec1u h\u00edt Trelegy Ellipta c\u00f3 […]\n","protected":false},"author":1,"featured_media":122669,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_cat":[89],"product_tag":[],"class_list":{"0":"post-122668","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-thuoc","8":"first","9":"instock","10":"shipping-taxable","11":"purchasable","12":"product-type-simple"},"acf":[],"_links":{"self":[{"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/product\/122668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/types\/product"}],"author":[{"embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/comments?post=122668"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/media\/122669"}],"wp:attachment":[{"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/media?parent=122668"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/product_cat?post=122668"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/product_tag?post=122668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

Tr\u00ecnh b\u00e0y<\/h3>\nS\u0110K: 500110439823<\/p>\nQuy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p c\u00f3 1 d\u1ee5ng c\u1ee5 h\u00edt ch\u1ee9a 30 li\u1ec1u h\u00edt<\/p>\nXu\u1ea5t x\u1ee9: V\u01b0\u01a1ng qu\u1ed1c Anh<\/p>\nH\u1ea1n s\u1eed d\u1ee5ng: 24 th\u00e1ng<\/p>\n

T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Trelegy Ellipta<\/h2>\n

Li\u1ec1u d\u00f9ng v\u00e0 c\u00e1ch s\u1eed d\u1ee5ng<\/h2>\n

L\u01b0u \u00fd \u0111\u1eb7c bi\u1ec7t khi s\u1eed d\u1ee5ng thu\u1ed1c<\/h2>\n

Tr\u00ecnh b\u00e0y<\/h3>\n
S\u0110K: 500110439823<\/p>\n
Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p c\u00f3 1 d\u1ee5ng c\u1ee5 h\u00edt ch\u1ee9a 30 li\u1ec1u h\u00edt<\/p>\n
Xu\u1ea5t x\u1ee9: V\u01b0\u01a1ng qu\u1ed1c Anh<\/p>\n
H\u1ea1n s\u1eed d\u1ee5ng: 24 th\u00e1ng<\/p>\n